INSIGHTS ON PHARMA LOGISTICS
-
Cryopreservation Best Practices For Cell & Gene Therapy Source Material
Industry experts share their experiences, including why and how cellular source materials are cryopreserved and why experience across cell types and methods matters.
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Over The Hurdles: Taking Psychedelics From Schedule I To Pharmacy
Learn how a partner with experience in handling scheduled substances and navigating FDA and DEA regulation can help you advance toward clinical research and drug development with ease.
-
Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?
Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.
-
Continuous, Continuous-Manufacturing8/18/2023
Upstream, downstream … Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, is all in on continuous manufacturing. It’s what we do, she says. Rather, it’s what her CDMO of choice does for her.
-
Global Supply Chains: How Do You Decide Where To Outsource?8/18/2023
Our experienced supply-chain professionals take a look at the rhyme-and-reason for supply chains and external partners spread out around the world.
-
Leave The Starting Materials To Your CDMO8/18/2023
Our professionals relay some experiences where drug sponsors attempted to take control of the starting materials, and not leave it to their CDMOs. You may want to help, but there are risks involved.
-
Know Your Supply Chain Analytics!8/18/2023
Two of our Outsourced Pharma Live speakers emphasize the importance of understanding all aspects of the analytics that will serve your drug substance and drug product throughout the supply chain.
PHARMA LOGISTICS SOLUTIONS
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
Contracting an in-country clinical depot helps bring costs and timelines under control.
-
Unlock an enhanced customer experience through digital transformation by applying real-time visibility into your supply chain using cross-functional workflows and data-driven insights.
-
Do you need a CDMO that will fill the gaps in the drug development process and focus on getting patients the treatments they need faster? Our team of experts at Singota is here to collaborate with you, customizing our services to meet your needs and hit your milestones.
-
How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.